📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Agalimmune

1.1 - Company Overview

Agalimmune Logo

Agalimmune

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of immunotherapeutic technology, licensing the Alphaject technology from the University of Massachusetts Medical School; located in London, UK and California, USA.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Agalimmune

Affimed Logo

Affimed

HQ: Germany Website
  • Description: Provider of innate cell engager (ICE) antibody therapeutics for cancer, including AFM13 (CD30/CD16A), AFM24 (EGFR-directed engaging NK cells and macrophages), and AFM28 (CD123/CD16A for AML), plus the ROCK platform for customizable ICEs, ongoing clinical trials, and partnerships with pharmaceutical companies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Affimed company profile →
X-Body Biosciences Logo

X-Body Biosciences

HQ: United States Website
  • Description: Provider of biotechnology R&D focused on discovering and developing compounds against therapeutic targets in oncology and ophthalmology, including discovery of human antibodies against high-value targets; engages in alliances with other corporations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full X-Body Biosciences company profile →
Osivax Logo

Osivax

HQ: France Website
  • Description: Provider of immunotherapy vaccines powered by the oligoDOM self-assembling nanoparticle platform to elicit potent T- and B-cell responses and enable universal vaccines against mutating pathogens. Pipeline includes OVX836, a universal influenza A vaccine targeting nucleoprotein; OVX033, a universal sarbecovirus vaccine targeting nucleocapsid; and PANHPVAX, a pan-strain HPV vaccine.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Osivax company profile →
BigHat Biosciences Logo

BigHat Biosciences

HQ: United States Website
  • Description: Provider of AI-guided antibody design and protein therapeutics via the Milliner platform integrating high-speed synthetic biology wet lab with machine learning to accelerate discovery and engineering; Reccy cloud-native LIMS/OS for instrument/robot control, scheduling, data management, and ML training; develops antibodies for oncology, inflammatory diseases, and immunology; partners with biopharma/biotech.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BigHat Biosciences company profile →
Selexis Logo

Selexis

HQ: Switzerland Website
  • Description: Provider of proprietary technology and highly specialized expertise for mammalian (suspension-adapted CHO-K1) cell line generation, helping translate scientific innovation into life-saving medicines for patients.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Selexis company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Agalimmune

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Agalimmune

2.2 - Growth funds investing in similar companies to Agalimmune

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Agalimmune

4.2 - Public trading comparable groups for Agalimmune

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Agalimmune

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Agalimmune

What does Agalimmune do?

Agalimmune is a provider of immunotherapeutic technology, licensing the Alphaject technology from the University of Massachusetts Medical School; located in London, UK and California, USA.

Who are Agalimmune's competitors?

Agalimmune's competitors and similar companies include Affimed, X-Body Biosciences, Osivax, BigHat Biosciences, and Selexis.

Where is Agalimmune headquartered?

Agalimmune is headquartered in United States.

How many employees does Agalimmune have?

Agalimmune has 1,000 employees 🔒.

When was Agalimmune founded?

Agalimmune was founded in 2010 🔒.

What sector and industry vertical is Agalimmune in?

Agalimmune is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Agalimmune

Who are the top strategic acquirers in Agalimmune's sector and industry

Top strategic M&A buyers and acquirers in Agalimmune's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Agalimmune?

Top strategic M&A buyers groups and sectors for Agalimmune include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Agalimmune's sector and industry vertical

Which are the top PE firms investing in Agalimmune's sector and industry vertical?

Top PE firms investing in Agalimmune's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Agalimmune's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Agalimmune's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Agalimmune's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Agalimmune include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Agalimmune's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Agalimmune?

The key public trading comparables and valuation benchmarks for Agalimmune include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Agalimmune for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Agalimmune with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Agalimmune's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Agalimmune with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Agalimmune's' sector and industry vertical?

Access recent funding rounds and capital raises in Agalimmune's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Agalimmune